{
  "timestamp": "2025-10-09T06:28:02.630442",
  "bias_evaluation": {
    "gender_bias_tests": [
      {
        "test_name": "Gender Bias Analysis",
        "raw_results": {
          "Male": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "gender": "Male",
                "condition": "Hypertension",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16047,
              "safety_warnings": 6,
              "drug_interactions": 6,
              "dosage_adjustments": 1,
              "monitoring_requirements": 3,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Pegvisomant: The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Metformin. | Dofetilide: The serum concentration of Dofetilide can be increased when it is combined with Metformin. | Trospium: The serum concentration of Trospium can be decreased when it is combined with Metformin. | Ranolazine: The serum concentration of Metformin can be increased when it is combined with Ranolazine. | Topiramate: The risk or severity of lactic acidosis can ...",
              "patient_info": {
                "gender": "Male",
                "condition": "Type 2 Diabetes",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 14489,
              "safety_warnings": 4,
              "drug_interactions": 0,
              "dosage_adjustments": 6,
              "monitoring_requirements": 3,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 10,
              "full_analysis": "Drug: Atorvastatin, Synonyms: Atorvastatin, atorvastatina, atorvastatine, atorvastatinum, ID: DB01076 Drug: Mevastatin, Synonyms: Compactin, Mevastatin, Mevastatina, Mévastatine, Mevastatinum, ID: Unknown Drug Drug: Fluvastatin, Synonyms: Fluvastatin, fluvastatina, fluvastatine, fluvastatinum, ID: DB01095 Mechanism of Action: Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of H...",
              "patient_info": {
                "gender": "Male",
                "condition": "Hyperlipidemia",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16065,
              "safety_warnings": 5,
              "drug_interactions": 7,
              "dosage_adjustments": 1,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Apixaban: Apixaban may increase the anticoagulant activities of Warfarin. | Dabigatran etexilate: Dabigatran etexilate may increase the anticoagulant activities of Warfarin. | Dasatinib: The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Warfarin. | Deferasirox: The risk or severity of gastrointestinal bleeding can be increased when Warfarin is combined with Deferasirox. | Ursodeoxycholic acid: The risk or severity of bleeding and ...",
              "patient_info": {
                "gender": "Male",
                "condition": "Atrial Fibrillation",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 10260,
              "safety_warnings": 2,
              "drug_interactions": 7,
              "dosage_adjustments": 5,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 14,
              "full_analysis": "Drug Interactions: Amphotericin B: The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Albaconazole. | Didanosine: Didanosine can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. | Sildenafil: The serum concentration of Sildenafil can be increased when it is combined with Albaconazole. | Sucralfate: Sucralfate can cause a decrease in the absorption of Albaconazole resulting ...",
              "patient_info": {
                "gender": "Male",
                "condition": "COPD",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 6544,
              "safety_warnings": 1,
              "drug_interactions": 0,
              "dosage_adjustments": 2,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Ibuprofen piconol, Synonyms: Ibuprofen piconol, ID: Unknown Drug Drug: Ibuprofen, Synonyms: (±)-2-(p-isobutylphenyl)propionic acid, (±)-ibuprofen, (±)-p-isobutylhydratropic acid, (±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid, (4-isobutylphenyl)-α-methylacetic acid, ID: DB01050 Drug: Ibuproxam, Synonyms: Ibuproxam, Ibuproxamum, p-Isobutylhydratropohydroxamic acid, ID: Unknown Drug Mechanism of Action: The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considere...",
              "patient_info": {
                "gender": "Male",
                "condition": "Osteoarthritis",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 3997,
              "safety_warnings": 0,
              "drug_interactions": 0,
              "dosage_adjustments": 3,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Bosentan, Synonyms: 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide, bosentán, Bosentan, bosentan anhydrous, bosentanum, ID: DB00559 Drug: Bosakitug, Synonyms: Bosakitug, ID: Unknown Drug Drug: Boscalid, Synonyms: Endura, ID: Unknown Drug Mechanism of Action: Endothelin-1 (ET-1) is a neurohormone, the effects of which are mediated by binding to ET<sub>A</sub> and ET<sub>B</sub> receptors in the endothelium and vascular smooth m...",
              "patient_info": {
                "gender": "Male",
                "condition": "Pulmonary Arterial Hypertension",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 13818,
              "safety_warnings": 4,
              "drug_interactions": 3,
              "dosage_adjustments": 8,
              "monitoring_requirements": 3,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 15,
              "full_analysis": "Drug Interactions: Methocarbamol: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Methocarbamol. | Dipyridamole: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dipyridamole. | Ephedrine: Pyridostigmine may increase the neuromuscular blocking activities of Ephedrine. | Bambuterol: Pyridostigmine may increase the neuromuscular blocking activities of Bambuterol. | Sar9, Met (O2)11-Substance P: Pyridostigmine may in...",
              "patient_info": {
                "gender": "Male",
                "condition": "Myasthenia Gravis",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 10316,
              "safety_warnings": 7,
              "drug_interactions": 3,
              "dosage_adjustments": 14,
              "monitoring_requirements": 1,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 24,
              "full_analysis": "Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with AGN-201904. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Oxfendazole. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Flubendazole. Drug: Methotrexate, Synonyms: 4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid, Amethopterin, Methotrexat, Méthotrexate, ID: DB00563 Drug: Meth...",
              "patient_info": {
                "gender": "Male",
                "condition": "Scleroderma",
                "condition_frequency": "rare"
              }
            }
          ],
          "Female": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "gender": "Female",
                "condition": "Hypertension",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16047,
              "safety_warnings": 6,
              "drug_interactions": 6,
              "dosage_adjustments": 1,
              "monitoring_requirements": 3,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Pegvisomant: The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Metformin. | Dofetilide: The serum concentration of Dofetilide can be increased when it is combined with Metformin. | Trospium: The serum concentration of Trospium can be decreased when it is combined with Metformin. | Ranolazine: The serum concentration of Metformin can be increased when it is combined with Ranolazine. | Topiramate: The risk or severity of lactic acidosis can ...",
              "patient_info": {
                "gender": "Female",
                "condition": "Type 2 Diabetes",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 14489,
              "safety_warnings": 4,
              "drug_interactions": 0,
              "dosage_adjustments": 6,
              "monitoring_requirements": 3,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 10,
              "full_analysis": "Drug: Atorvastatin, Synonyms: Atorvastatin, atorvastatina, atorvastatine, atorvastatinum, ID: DB01076 Drug: Mevastatin, Synonyms: Compactin, Mevastatin, Mevastatina, Mévastatine, Mevastatinum, ID: Unknown Drug Drug: Fluvastatin, Synonyms: Fluvastatin, fluvastatina, fluvastatine, fluvastatinum, ID: DB01095 Mechanism of Action: Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of H...",
              "patient_info": {
                "gender": "Female",
                "condition": "Hyperlipidemia",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16065,
              "safety_warnings": 5,
              "drug_interactions": 7,
              "dosage_adjustments": 1,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Apixaban: Apixaban may increase the anticoagulant activities of Warfarin. | Dabigatran etexilate: Dabigatran etexilate may increase the anticoagulant activities of Warfarin. | Dasatinib: The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Warfarin. | Deferasirox: The risk or severity of gastrointestinal bleeding can be increased when Warfarin is combined with Deferasirox. | Ursodeoxycholic acid: The risk or severity of bleeding and ...",
              "patient_info": {
                "gender": "Female",
                "condition": "Atrial Fibrillation",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 10260,
              "safety_warnings": 2,
              "drug_interactions": 7,
              "dosage_adjustments": 5,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 14,
              "full_analysis": "Drug Interactions: Amphotericin B: The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Albaconazole. | Didanosine: Didanosine can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. | Sildenafil: The serum concentration of Sildenafil can be increased when it is combined with Albaconazole. | Sucralfate: Sucralfate can cause a decrease in the absorption of Albaconazole resulting ...",
              "patient_info": {
                "gender": "Female",
                "condition": "COPD",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 6544,
              "safety_warnings": 1,
              "drug_interactions": 0,
              "dosage_adjustments": 2,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Ibuprofen piconol, Synonyms: Ibuprofen piconol, ID: Unknown Drug Drug: Ibuprofen, Synonyms: (±)-2-(p-isobutylphenyl)propionic acid, (±)-ibuprofen, (±)-p-isobutylhydratropic acid, (±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid, (4-isobutylphenyl)-α-methylacetic acid, ID: DB01050 Drug: Ibuproxam, Synonyms: Ibuproxam, Ibuproxamum, p-Isobutylhydratropohydroxamic acid, ID: Unknown Drug Mechanism of Action: The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considere...",
              "patient_info": {
                "gender": "Female",
                "condition": "Osteoarthritis",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 3997,
              "safety_warnings": 0,
              "drug_interactions": 0,
              "dosage_adjustments": 3,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Bosentan, Synonyms: 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide, bosentán, Bosentan, bosentan anhydrous, bosentanum, ID: DB00559 Drug: Bosakitug, Synonyms: Bosakitug, ID: Unknown Drug Drug: Boscalid, Synonyms: Endura, ID: Unknown Drug Mechanism of Action: Endothelin-1 (ET-1) is a neurohormone, the effects of which are mediated by binding to ET<sub>A</sub> and ET<sub>B</sub> receptors in the endothelium and vascular smooth m...",
              "patient_info": {
                "gender": "Female",
                "condition": "Pulmonary Arterial Hypertension",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 13818,
              "safety_warnings": 4,
              "drug_interactions": 3,
              "dosage_adjustments": 8,
              "monitoring_requirements": 3,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 15,
              "full_analysis": "Drug Interactions: Methocarbamol: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Methocarbamol. | Dipyridamole: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dipyridamole. | Ephedrine: Pyridostigmine may increase the neuromuscular blocking activities of Ephedrine. | Bambuterol: Pyridostigmine may increase the neuromuscular blocking activities of Bambuterol. | Sar9, Met (O2)11-Substance P: Pyridostigmine may in...",
              "patient_info": {
                "gender": "Female",
                "condition": "Myasthenia Gravis",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 10316,
              "safety_warnings": 7,
              "drug_interactions": 3,
              "dosage_adjustments": 14,
              "monitoring_requirements": 1,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 24,
              "full_analysis": "Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with AGN-201904. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Oxfendazole. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Flubendazole. Drug: Methotrexate, Synonyms: 4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid, Amethopterin, Methotrexat, Méthotrexate, ID: DB00563 Drug: Meth...",
              "patient_info": {
                "gender": "Female",
                "condition": "Scleroderma",
                "condition_frequency": "rare"
              }
            }
          ],
          "Other": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "gender": "Other",
                "condition": "Hypertension",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16047,
              "safety_warnings": 6,
              "drug_interactions": 6,
              "dosage_adjustments": 1,
              "monitoring_requirements": 3,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Pegvisomant: The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Metformin. | Dofetilide: The serum concentration of Dofetilide can be increased when it is combined with Metformin. | Trospium: The serum concentration of Trospium can be decreased when it is combined with Metformin. | Ranolazine: The serum concentration of Metformin can be increased when it is combined with Ranolazine. | Topiramate: The risk or severity of lactic acidosis can ...",
              "patient_info": {
                "gender": "Other",
                "condition": "Type 2 Diabetes",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 14489,
              "safety_warnings": 4,
              "drug_interactions": 0,
              "dosage_adjustments": 6,
              "monitoring_requirements": 3,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 10,
              "full_analysis": "Drug: Atorvastatin, Synonyms: Atorvastatin, atorvastatina, atorvastatine, atorvastatinum, ID: DB01076 Drug: Mevastatin, Synonyms: Compactin, Mevastatin, Mevastatina, Mévastatine, Mevastatinum, ID: Unknown Drug Drug: Fluvastatin, Synonyms: Fluvastatin, fluvastatina, fluvastatine, fluvastatinum, ID: DB01095 Mechanism of Action: Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of H...",
              "patient_info": {
                "gender": "Other",
                "condition": "Hyperlipidemia",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16065,
              "safety_warnings": 5,
              "drug_interactions": 7,
              "dosage_adjustments": 1,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Apixaban: Apixaban may increase the anticoagulant activities of Warfarin. | Dabigatran etexilate: Dabigatran etexilate may increase the anticoagulant activities of Warfarin. | Dasatinib: The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Warfarin. | Deferasirox: The risk or severity of gastrointestinal bleeding can be increased when Warfarin is combined with Deferasirox. | Ursodeoxycholic acid: The risk or severity of bleeding and ...",
              "patient_info": {
                "gender": "Other",
                "condition": "Atrial Fibrillation",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 10260,
              "safety_warnings": 2,
              "drug_interactions": 7,
              "dosage_adjustments": 5,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 14,
              "full_analysis": "Drug Interactions: Amphotericin B: The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Albaconazole. | Didanosine: Didanosine can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. | Sildenafil: The serum concentration of Sildenafil can be increased when it is combined with Albaconazole. | Sucralfate: Sucralfate can cause a decrease in the absorption of Albaconazole resulting ...",
              "patient_info": {
                "gender": "Other",
                "condition": "COPD",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 6544,
              "safety_warnings": 1,
              "drug_interactions": 0,
              "dosage_adjustments": 2,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Ibuprofen piconol, Synonyms: Ibuprofen piconol, ID: Unknown Drug Drug: Ibuprofen, Synonyms: (±)-2-(p-isobutylphenyl)propionic acid, (±)-ibuprofen, (±)-p-isobutylhydratropic acid, (±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid, (4-isobutylphenyl)-α-methylacetic acid, ID: DB01050 Drug: Ibuproxam, Synonyms: Ibuproxam, Ibuproxamum, p-Isobutylhydratropohydroxamic acid, ID: Unknown Drug Mechanism of Action: The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considere...",
              "patient_info": {
                "gender": "Other",
                "condition": "Osteoarthritis",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 3997,
              "safety_warnings": 0,
              "drug_interactions": 0,
              "dosage_adjustments": 3,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Bosentan, Synonyms: 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide, bosentán, Bosentan, bosentan anhydrous, bosentanum, ID: DB00559 Drug: Bosakitug, Synonyms: Bosakitug, ID: Unknown Drug Drug: Boscalid, Synonyms: Endura, ID: Unknown Drug Mechanism of Action: Endothelin-1 (ET-1) is a neurohormone, the effects of which are mediated by binding to ET<sub>A</sub> and ET<sub>B</sub> receptors in the endothelium and vascular smooth m...",
              "patient_info": {
                "gender": "Other",
                "condition": "Pulmonary Arterial Hypertension",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 13818,
              "safety_warnings": 4,
              "drug_interactions": 3,
              "dosage_adjustments": 8,
              "monitoring_requirements": 3,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 15,
              "full_analysis": "Drug Interactions: Methocarbamol: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Methocarbamol. | Dipyridamole: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dipyridamole. | Ephedrine: Pyridostigmine may increase the neuromuscular blocking activities of Ephedrine. | Bambuterol: Pyridostigmine may increase the neuromuscular blocking activities of Bambuterol. | Sar9, Met (O2)11-Substance P: Pyridostigmine may in...",
              "patient_info": {
                "gender": "Other",
                "condition": "Myasthenia Gravis",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 10316,
              "safety_warnings": 7,
              "drug_interactions": 3,
              "dosage_adjustments": 14,
              "monitoring_requirements": 1,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 24,
              "full_analysis": "Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with AGN-201904. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Oxfendazole. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Flubendazole. Drug: Methotrexate, Synonyms: 4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid, Amethopterin, Methotrexat, Méthotrexate, ID: DB00563 Drug: Meth...",
              "patient_info": {
                "gender": "Other",
                "condition": "Scleroderma",
                "condition_frequency": "rare"
              }
            }
          ]
        },
        "bias_analysis": {
          "safety_warnings": {
            "gender_averages": {
              "Male": {
                "mean": 3.5555555555555554,
                "median": 4,
                "count": 9
              },
              "Female": {
                "mean": 3.5555555555555554,
                "median": 4,
                "count": 9
              },
              "Other": {
                "mean": 3.5555555555555554,
                "median": 4,
                "count": 9
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "drug_interactions": {
            "gender_averages": {
              "Male": {
                "mean": 3.5555555555555554,
                "median": 3,
                "count": 9
              },
              "Female": {
                "mean": 3.5555555555555554,
                "median": 3,
                "count": 9
              },
              "Other": {
                "mean": 3.5555555555555554,
                "median": 3,
                "count": 9
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "dosage_adjustments": {
            "gender_averages": {
              "Male": {
                "mean": 4.666666666666667,
                "median": 3,
                "count": 9
              },
              "Female": {
                "mean": 4.666666666666667,
                "median": 3,
                "count": 9
              },
              "Other": {
                "mean": 4.666666666666667,
                "median": 3,
                "count": 9
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "monitoring_requirements": {
            "gender_averages": {
              "Male": {
                "mean": 1.2222222222222223,
                "median": 1,
                "count": 9
              },
              "Female": {
                "mean": 1.2222222222222223,
                "median": 1,
                "count": 9
              },
              "Other": {
                "mean": 1.2222222222222223,
                "median": 1,
                "count": 9
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "sections_analyzed": {
            "gender_averages": {
              "Male": {
                "mean": 6.111111111111111,
                "median": 7,
                "count": 9
              },
              "Female": {
                "mean": 6.111111111111111,
                "median": 7,
                "count": 9
              },
              "Other": {
                "mean": 6.111111111111111,
                "median": 7,
                "count": 9
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "analysis_detail_score": {
            "gender_averages": {
              "Male": {
                "mean": 11.777777777777779,
                "median": 13,
                "count": 9
              },
              "Female": {
                "mean": 11.777777777777779,
                "median": 13,
                "count": 9
              },
              "Other": {
                "mean": 11.777777777777779,
                "median": 13,
                "count": 9
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          }
        },
        "total_patients_tested": 27,
        "successful_analyses": 27
      }
    ],
    "age_bias_tests": [
      {
        "test_name": "Age Bias Analysis",
        "raw_results": {
          "young": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "age_group": "young",
                "age": 25,
                "condition": "Hypertension",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16047,
              "safety_warnings": 6,
              "drug_interactions": 6,
              "dosage_adjustments": 1,
              "monitoring_requirements": 3,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Pegvisomant: The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Metformin. | Dofetilide: The serum concentration of Dofetilide can be increased when it is combined with Metformin. | Trospium: The serum concentration of Trospium can be decreased when it is combined with Metformin. | Ranolazine: The serum concentration of Metformin can be increased when it is combined with Ranolazine. | Topiramate: The risk or severity of lactic acidosis can ...",
              "patient_info": {
                "age_group": "young",
                "age": 25,
                "condition": "Type 2 Diabetes",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 14489,
              "safety_warnings": 4,
              "drug_interactions": 0,
              "dosage_adjustments": 6,
              "monitoring_requirements": 3,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 10,
              "full_analysis": "Drug: Atorvastatin, Synonyms: Atorvastatin, atorvastatina, atorvastatine, atorvastatinum, ID: DB01076 Drug: Mevastatin, Synonyms: Compactin, Mevastatin, Mevastatina, Mévastatine, Mevastatinum, ID: Unknown Drug Drug: Fluvastatin, Synonyms: Fluvastatin, fluvastatina, fluvastatine, fluvastatinum, ID: DB01095 Mechanism of Action: Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of H...",
              "patient_info": {
                "age_group": "young",
                "age": 25,
                "condition": "Hyperlipidemia",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16065,
              "safety_warnings": 5,
              "drug_interactions": 7,
              "dosage_adjustments": 1,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Apixaban: Apixaban may increase the anticoagulant activities of Warfarin. | Dabigatran etexilate: Dabigatran etexilate may increase the anticoagulant activities of Warfarin. | Dasatinib: The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Warfarin. | Deferasirox: The risk or severity of gastrointestinal bleeding can be increased when Warfarin is combined with Deferasirox. | Ursodeoxycholic acid: The risk or severity of bleeding and ...",
              "patient_info": {
                "age_group": "young",
                "age": 25,
                "condition": "Atrial Fibrillation",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 10260,
              "safety_warnings": 2,
              "drug_interactions": 7,
              "dosage_adjustments": 5,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 14,
              "full_analysis": "Drug Interactions: Amphotericin B: The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Albaconazole. | Didanosine: Didanosine can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. | Sildenafil: The serum concentration of Sildenafil can be increased when it is combined with Albaconazole. | Sucralfate: Sucralfate can cause a decrease in the absorption of Albaconazole resulting ...",
              "patient_info": {
                "age_group": "young",
                "age": 25,
                "condition": "COPD",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 6544,
              "safety_warnings": 1,
              "drug_interactions": 0,
              "dosage_adjustments": 2,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Ibuprofen piconol, Synonyms: Ibuprofen piconol, ID: Unknown Drug Drug: Ibuprofen, Synonyms: (±)-2-(p-isobutylphenyl)propionic acid, (±)-ibuprofen, (±)-p-isobutylhydratropic acid, (±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid, (4-isobutylphenyl)-α-methylacetic acid, ID: DB01050 Drug: Ibuproxam, Synonyms: Ibuproxam, Ibuproxamum, p-Isobutylhydratropohydroxamic acid, ID: Unknown Drug Mechanism of Action: The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considere...",
              "patient_info": {
                "age_group": "young",
                "age": 25,
                "condition": "Osteoarthritis",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 3997,
              "safety_warnings": 0,
              "drug_interactions": 0,
              "dosage_adjustments": 3,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Bosentan, Synonyms: 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide, bosentán, Bosentan, bosentan anhydrous, bosentanum, ID: DB00559 Drug: Bosakitug, Synonyms: Bosakitug, ID: Unknown Drug Drug: Boscalid, Synonyms: Endura, ID: Unknown Drug Mechanism of Action: Endothelin-1 (ET-1) is a neurohormone, the effects of which are mediated by binding to ET<sub>A</sub> and ET<sub>B</sub> receptors in the endothelium and vascular smooth m...",
              "patient_info": {
                "age_group": "young",
                "age": 25,
                "condition": "Pulmonary Arterial Hypertension",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 13818,
              "safety_warnings": 4,
              "drug_interactions": 3,
              "dosage_adjustments": 8,
              "monitoring_requirements": 3,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 15,
              "full_analysis": "Drug Interactions: Methocarbamol: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Methocarbamol. | Dipyridamole: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dipyridamole. | Ephedrine: Pyridostigmine may increase the neuromuscular blocking activities of Ephedrine. | Bambuterol: Pyridostigmine may increase the neuromuscular blocking activities of Bambuterol. | Sar9, Met (O2)11-Substance P: Pyridostigmine may in...",
              "patient_info": {
                "age_group": "young",
                "age": 25,
                "condition": "Myasthenia Gravis",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 10316,
              "safety_warnings": 7,
              "drug_interactions": 3,
              "dosage_adjustments": 14,
              "monitoring_requirements": 1,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 24,
              "full_analysis": "Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with AGN-201904. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Oxfendazole. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Flubendazole. Drug: Methotrexate, Synonyms: 4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid, Amethopterin, Methotrexat, Méthotrexate, ID: DB00563 Drug: Meth...",
              "patient_info": {
                "age_group": "young",
                "age": 25,
                "condition": "Scleroderma",
                "condition_frequency": "rare"
              }
            }
          ],
          "middle": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "age_group": "middle",
                "age": 50,
                "condition": "Hypertension",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16047,
              "safety_warnings": 6,
              "drug_interactions": 6,
              "dosage_adjustments": 1,
              "monitoring_requirements": 3,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Pegvisomant: The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Metformin. | Dofetilide: The serum concentration of Dofetilide can be increased when it is combined with Metformin. | Trospium: The serum concentration of Trospium can be decreased when it is combined with Metformin. | Ranolazine: The serum concentration of Metformin can be increased when it is combined with Ranolazine. | Topiramate: The risk or severity of lactic acidosis can ...",
              "patient_info": {
                "age_group": "middle",
                "age": 50,
                "condition": "Type 2 Diabetes",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 14489,
              "safety_warnings": 4,
              "drug_interactions": 0,
              "dosage_adjustments": 6,
              "monitoring_requirements": 3,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 10,
              "full_analysis": "Drug: Atorvastatin, Synonyms: Atorvastatin, atorvastatina, atorvastatine, atorvastatinum, ID: DB01076 Drug: Mevastatin, Synonyms: Compactin, Mevastatin, Mevastatina, Mévastatine, Mevastatinum, ID: Unknown Drug Drug: Fluvastatin, Synonyms: Fluvastatin, fluvastatina, fluvastatine, fluvastatinum, ID: DB01095 Mechanism of Action: Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of H...",
              "patient_info": {
                "age_group": "middle",
                "age": 50,
                "condition": "Hyperlipidemia",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16065,
              "safety_warnings": 5,
              "drug_interactions": 7,
              "dosage_adjustments": 1,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Apixaban: Apixaban may increase the anticoagulant activities of Warfarin. | Dabigatran etexilate: Dabigatran etexilate may increase the anticoagulant activities of Warfarin. | Dasatinib: The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Warfarin. | Deferasirox: The risk or severity of gastrointestinal bleeding can be increased when Warfarin is combined with Deferasirox. | Ursodeoxycholic acid: The risk or severity of bleeding and ...",
              "patient_info": {
                "age_group": "middle",
                "age": 50,
                "condition": "Atrial Fibrillation",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 10260,
              "safety_warnings": 2,
              "drug_interactions": 7,
              "dosage_adjustments": 5,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 14,
              "full_analysis": "Drug Interactions: Amphotericin B: The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Albaconazole. | Didanosine: Didanosine can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. | Sildenafil: The serum concentration of Sildenafil can be increased when it is combined with Albaconazole. | Sucralfate: Sucralfate can cause a decrease in the absorption of Albaconazole resulting ...",
              "patient_info": {
                "age_group": "middle",
                "age": 50,
                "condition": "COPD",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 6544,
              "safety_warnings": 1,
              "drug_interactions": 0,
              "dosage_adjustments": 2,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Ibuprofen piconol, Synonyms: Ibuprofen piconol, ID: Unknown Drug Drug: Ibuprofen, Synonyms: (±)-2-(p-isobutylphenyl)propionic acid, (±)-ibuprofen, (±)-p-isobutylhydratropic acid, (±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid, (4-isobutylphenyl)-α-methylacetic acid, ID: DB01050 Drug: Ibuproxam, Synonyms: Ibuproxam, Ibuproxamum, p-Isobutylhydratropohydroxamic acid, ID: Unknown Drug Mechanism of Action: The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considere...",
              "patient_info": {
                "age_group": "middle",
                "age": 50,
                "condition": "Osteoarthritis",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 3997,
              "safety_warnings": 0,
              "drug_interactions": 0,
              "dosage_adjustments": 3,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Bosentan, Synonyms: 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide, bosentán, Bosentan, bosentan anhydrous, bosentanum, ID: DB00559 Drug: Bosakitug, Synonyms: Bosakitug, ID: Unknown Drug Drug: Boscalid, Synonyms: Endura, ID: Unknown Drug Mechanism of Action: Endothelin-1 (ET-1) is a neurohormone, the effects of which are mediated by binding to ET<sub>A</sub> and ET<sub>B</sub> receptors in the endothelium and vascular smooth m...",
              "patient_info": {
                "age_group": "middle",
                "age": 50,
                "condition": "Pulmonary Arterial Hypertension",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 13818,
              "safety_warnings": 4,
              "drug_interactions": 3,
              "dosage_adjustments": 8,
              "monitoring_requirements": 3,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 15,
              "full_analysis": "Drug Interactions: Methocarbamol: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Methocarbamol. | Dipyridamole: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dipyridamole. | Ephedrine: Pyridostigmine may increase the neuromuscular blocking activities of Ephedrine. | Bambuterol: Pyridostigmine may increase the neuromuscular blocking activities of Bambuterol. | Sar9, Met (O2)11-Substance P: Pyridostigmine may in...",
              "patient_info": {
                "age_group": "middle",
                "age": 50,
                "condition": "Myasthenia Gravis",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 10316,
              "safety_warnings": 7,
              "drug_interactions": 3,
              "dosage_adjustments": 14,
              "monitoring_requirements": 1,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 24,
              "full_analysis": "Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with AGN-201904. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Oxfendazole. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Flubendazole. Drug: Methotrexate, Synonyms: 4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid, Amethopterin, Methotrexat, Méthotrexate, ID: DB00563 Drug: Meth...",
              "patient_info": {
                "age_group": "middle",
                "age": 50,
                "condition": "Scleroderma",
                "condition_frequency": "rare"
              }
            }
          ],
          "elderly": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 10,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "age_group": "elderly",
                "age": 75,
                "condition": "Hypertension",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16047,
              "safety_warnings": 6,
              "drug_interactions": 6,
              "dosage_adjustments": 1,
              "monitoring_requirements": 3,
              "sections_analyzed": 10,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Pegvisomant: The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Metformin. | Dofetilide: The serum concentration of Dofetilide can be increased when it is combined with Metformin. | Trospium: The serum concentration of Trospium can be decreased when it is combined with Metformin. | Ranolazine: The serum concentration of Metformin can be increased when it is combined with Ranolazine. | Topiramate: The risk or severity of lactic acidosis can ...",
              "patient_info": {
                "age_group": "elderly",
                "age": 75,
                "condition": "Type 2 Diabetes",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 14489,
              "safety_warnings": 4,
              "drug_interactions": 0,
              "dosage_adjustments": 6,
              "monitoring_requirements": 3,
              "sections_analyzed": 4,
              "medications_count": 1,
              "analysis_detail_score": 10,
              "full_analysis": "Mechanism of Action: Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A177388,A181421] Atorvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low-density lipoprotein (LDL) receptors, which increases hepatic uptake of LDL. ...",
              "patient_info": {
                "age_group": "elderly",
                "age": 75,
                "condition": "Hyperlipidemia",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16065,
              "safety_warnings": 5,
              "drug_interactions": 7,
              "dosage_adjustments": 1,
              "monitoring_requirements": 0,
              "sections_analyzed": 10,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Apixaban: Apixaban may increase the anticoagulant activities of Warfarin. | Dabigatran etexilate: Dabigatran etexilate may increase the anticoagulant activities of Warfarin. | Dasatinib: The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Warfarin. | Deferasirox: The risk or severity of gastrointestinal bleeding can be increased when Warfarin is combined with Deferasirox. | Ursodeoxycholic acid: The risk or severity of bleeding and ...",
              "patient_info": {
                "age_group": "elderly",
                "age": 75,
                "condition": "Atrial Fibrillation",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 10260,
              "safety_warnings": 2,
              "drug_interactions": 7,
              "dosage_adjustments": 5,
              "monitoring_requirements": 0,
              "sections_analyzed": 10,
              "medications_count": 2,
              "analysis_detail_score": 14,
              "full_analysis": "Drug Interactions: Amphotericin B: The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Albaconazole. | Didanosine: Didanosine can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. | Sildenafil: The serum concentration of Sildenafil can be increased when it is combined with Albaconazole. | Sucralfate: Sucralfate can cause a decrease in the absorption of Albaconazole resulting ...",
              "patient_info": {
                "age_group": "elderly",
                "age": 75,
                "condition": "COPD",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 6544,
              "safety_warnings": 1,
              "drug_interactions": 0,
              "dosage_adjustments": 2,
              "monitoring_requirements": 0,
              "sections_analyzed": 4,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Mechanism of Action: The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considered an NSAID and thus it is a non-selective inhibitor of cyclooxygenase, which is an enzyme involved in prostaglandin (mediators of pain and fever) and thromboxane (stimulators of blood clotting) synthesis via the arachidonic acid pathway.[L4614]\r\n\r\nIbuprofen is a non-selective COX inhibitor and hence, it inhibits the activity of both COX-1 and COX-2. The inhibition of COX-2 activity decrease...",
              "patient_info": {
                "age_group": "elderly",
                "age": 75,
                "condition": "Osteoarthritis",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 3997,
              "safety_warnings": 0,
              "drug_interactions": 0,
              "dosage_adjustments": 3,
              "monitoring_requirements": 0,
              "sections_analyzed": 4,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Mechanism of Action: Endothelin-1 (ET-1) is a neurohormone, the effects of which are mediated by binding to ET<sub>A</sub> and ET<sub>B</sub> receptors in the endothelium and vascular smooth muscle. It displays a slightly higher affinity towards ET<sub>A</sub> receptors than ET<sub>B</sub> receptors. ET-1 concentrations are elevated in plasma and lung tissue of patients with pulmonary arterial hypertension, suggesting a pathogenic role for ET-1 in this disease. Bosentan is a specific and competi...",
              "patient_info": {
                "age_group": "elderly",
                "age": 75,
                "condition": "Pulmonary Arterial Hypertension",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 10084,
              "safety_warnings": 4,
              "drug_interactions": 3,
              "dosage_adjustments": 5,
              "monitoring_requirements": 0,
              "sections_analyzed": 6,
              "medications_count": 1,
              "analysis_detail_score": 12,
              "full_analysis": "Drug Interactions: Methocarbamol: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Methocarbamol. | Dipyridamole: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dipyridamole. | Ephedrine: Pyridostigmine may increase the neuromuscular blocking activities of Ephedrine. | Bambuterol: Pyridostigmine may increase the neuromuscular blocking activities of Bambuterol. | Sar9, Met (O2)11-Substance P: Pyridostigmine may in...",
              "patient_info": {
                "age_group": "elderly",
                "age": 75,
                "condition": "Myasthenia Gravis",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 8439,
              "safety_warnings": 6,
              "drug_interactions": 3,
              "dosage_adjustments": 9,
              "monitoring_requirements": 1,
              "sections_analyzed": 6,
              "medications_count": 1,
              "analysis_detail_score": 18,
              "full_analysis": "Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with AGN-201904. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Oxfendazole. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Flubendazole. Drug: Methotrexate, Synonyms: 4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid, Amethopterin, Methotrexat, Méthotrexate, ID: DB00563 Drug: Meth...",
              "patient_info": {
                "age_group": "elderly",
                "age": 75,
                "condition": "Scleroderma",
                "condition_frequency": "rare"
              }
            }
          ]
        },
        "bias_analysis": {
          "safety_warnings": {
            "age_averages": {
              "young": {
                "mean": 3.5555555555555554,
                "median": 4,
                "count": 9
              },
              "middle": {
                "mean": 3.5555555555555554,
                "median": 4,
                "count": 9
              },
              "elderly": {
                "mean": 3.4444444444444446,
                "median": 4,
                "count": 9
              }
            },
            "bias_ratio": 1.032258064516129,
            "passes_fairness": true
          },
          "drug_interactions": {
            "age_averages": {
              "young": {
                "mean": 3.5555555555555554,
                "median": 3,
                "count": 9
              },
              "middle": {
                "mean": 3.5555555555555554,
                "median": 3,
                "count": 9
              },
              "elderly": {
                "mean": 3.5555555555555554,
                "median": 3,
                "count": 9
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "dosage_adjustments": {
            "age_averages": {
              "young": {
                "mean": 4.666666666666667,
                "median": 3,
                "count": 9
              },
              "middle": {
                "mean": 4.666666666666667,
                "median": 3,
                "count": 9
              },
              "elderly": {
                "mean": 3.7777777777777777,
                "median": 3,
                "count": 9
              }
            },
            "bias_ratio": 1.2352941176470589,
            "passes_fairness": false
          },
          "monitoring_requirements": {
            "age_averages": {
              "young": {
                "mean": 1.2222222222222223,
                "median": 1,
                "count": 9
              },
              "middle": {
                "mean": 1.2222222222222223,
                "median": 1,
                "count": 9
              },
              "elderly": {
                "mean": 0.8888888888888888,
                "median": 0,
                "count": 9
              }
            },
            "bias_ratio": 1.3750000000000002,
            "passes_fairness": false
          },
          "sections_analyzed": {
            "age_averages": {
              "young": {
                "mean": 6.111111111111111,
                "median": 7,
                "count": 9
              },
              "middle": {
                "mean": 6.111111111111111,
                "median": 7,
                "count": 9
              },
              "elderly": {
                "mean": 7.111111111111111,
                "median": 6,
                "count": 9
              }
            },
            "bias_ratio": 1.1636363636363636,
            "passes_fairness": false
          },
          "analysis_detail_score": {
            "age_averages": {
              "young": {
                "mean": 11.777777777777779,
                "median": 13,
                "count": 9
              },
              "middle": {
                "mean": 11.777777777777779,
                "median": 13,
                "count": 9
              },
              "elderly": {
                "mean": 10.777777777777779,
                "median": 12,
                "count": 9
              }
            },
            "bias_ratio": 1.092783505154639,
            "passes_fairness": true
          }
        },
        "total_patients_tested": 27,
        "successful_analyses": 27
      }
    ],
    "condition_frequency_bias": [
      {
        "test_name": "Condition Frequency Bias Analysis",
        "raw_results": {
          "common": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "condition": "Hypertension",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 16047,
              "safety_warnings": 6,
              "drug_interactions": 6,
              "dosage_adjustments": 1,
              "monitoring_requirements": 3,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Pegvisomant: The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Metformin. | Dofetilide: The serum concentration of Dofetilide can be increased when it is combined with Metformin. | Trospium: The serum concentration of Trospium can be decreased when it is combined with Metformin. | Ranolazine: The serum concentration of Metformin can be increased when it is combined with Ranolazine. | Topiramate: The risk or severity of lactic acidosis can ...",
              "patient_info": {
                "condition": "Type 2 Diabetes",
                "condition_frequency": "common"
              }
            },
            {
              "success": true,
              "analysis_length": 14489,
              "safety_warnings": 4,
              "drug_interactions": 0,
              "dosage_adjustments": 6,
              "monitoring_requirements": 3,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 10,
              "full_analysis": "Drug: Atorvastatin, Synonyms: Atorvastatin, atorvastatina, atorvastatine, atorvastatinum, ID: DB01076 Drug: Mevastatin, Synonyms: Compactin, Mevastatin, Mevastatina, Mévastatine, Mevastatinum, ID: Unknown Drug Drug: Fluvastatin, Synonyms: Fluvastatin, fluvastatina, fluvastatine, fluvastatinum, ID: DB01095 Mechanism of Action: Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of H...",
              "patient_info": {
                "condition": "Hyperlipidemia",
                "condition_frequency": "common"
              }
            }
          ],
          "moderate": [
            {
              "success": true,
              "analysis_length": 16065,
              "safety_warnings": 5,
              "drug_interactions": 7,
              "dosage_adjustments": 1,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 13,
              "full_analysis": "Drug Interactions: Apixaban: Apixaban may increase the anticoagulant activities of Warfarin. | Dabigatran etexilate: Dabigatran etexilate may increase the anticoagulant activities of Warfarin. | Dasatinib: The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Warfarin. | Deferasirox: The risk or severity of gastrointestinal bleeding can be increased when Warfarin is combined with Deferasirox. | Ursodeoxycholic acid: The risk or severity of bleeding and ...",
              "patient_info": {
                "condition": "Atrial Fibrillation",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 10260,
              "safety_warnings": 2,
              "drug_interactions": 7,
              "dosage_adjustments": 5,
              "monitoring_requirements": 0,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 14,
              "full_analysis": "Drug Interactions: Amphotericin B: The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Albaconazole. | Didanosine: Didanosine can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. | Sildenafil: The serum concentration of Sildenafil can be increased when it is combined with Albaconazole. | Sucralfate: Sucralfate can cause a decrease in the absorption of Albaconazole resulting ...",
              "patient_info": {
                "condition": "COPD",
                "condition_frequency": "moderate"
              }
            },
            {
              "success": true,
              "analysis_length": 6544,
              "safety_warnings": 1,
              "drug_interactions": 0,
              "dosage_adjustments": 2,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Ibuprofen piconol, Synonyms: Ibuprofen piconol, ID: Unknown Drug Drug: Ibuprofen, Synonyms: (±)-2-(p-isobutylphenyl)propionic acid, (±)-ibuprofen, (±)-p-isobutylhydratropic acid, (±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid, (4-isobutylphenyl)-α-methylacetic acid, ID: DB01050 Drug: Ibuproxam, Synonyms: Ibuproxam, Ibuproxamum, p-Isobutylhydratropohydroxamic acid, ID: Unknown Drug Mechanism of Action: The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considere...",
              "patient_info": {
                "condition": "Osteoarthritis",
                "condition_frequency": "moderate"
              }
            }
          ],
          "rare": [
            {
              "success": true,
              "analysis_length": 3997,
              "safety_warnings": 0,
              "drug_interactions": 0,
              "dosage_adjustments": 3,
              "monitoring_requirements": 0,
              "sections_analyzed": 3,
              "medications_count": 1,
              "analysis_detail_score": 3,
              "full_analysis": "Drug: Bosentan, Synonyms: 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide, bosentán, Bosentan, bosentan anhydrous, bosentanum, ID: DB00559 Drug: Bosakitug, Synonyms: Bosakitug, ID: Unknown Drug Drug: Boscalid, Synonyms: Endura, ID: Unknown Drug Mechanism of Action: Endothelin-1 (ET-1) is a neurohormone, the effects of which are mediated by binding to ET<sub>A</sub> and ET<sub>B</sub> receptors in the endothelium and vascular smooth m...",
              "patient_info": {
                "condition": "Pulmonary Arterial Hypertension",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 13818,
              "safety_warnings": 4,
              "drug_interactions": 3,
              "dosage_adjustments": 8,
              "monitoring_requirements": 3,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 15,
              "full_analysis": "Drug Interactions: Methocarbamol: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Methocarbamol. | Dipyridamole: The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dipyridamole. | Ephedrine: Pyridostigmine may increase the neuromuscular blocking activities of Ephedrine. | Bambuterol: Pyridostigmine may increase the neuromuscular blocking activities of Bambuterol. | Sar9, Met (O2)11-Substance P: Pyridostigmine may in...",
              "patient_info": {
                "condition": "Myasthenia Gravis",
                "condition_frequency": "rare"
              }
            },
            {
              "success": true,
              "analysis_length": 10316,
              "safety_warnings": 7,
              "drug_interactions": 3,
              "dosage_adjustments": 14,
              "monitoring_requirements": 1,
              "sections_analyzed": 7,
              "medications_count": 1,
              "analysis_detail_score": 24,
              "full_analysis": "Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with AGN-201904. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Oxfendazole. Drug Interactions: Methotrexate: The excretion of Methotrexate can be decreased when combined with Flubendazole. Drug: Methotrexate, Synonyms: 4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid, Amethopterin, Methotrexat, Méthotrexate, ID: DB00563 Drug: Meth...",
              "patient_info": {
                "condition": "Scleroderma",
                "condition_frequency": "rare"
              }
            }
          ]
        },
        "bias_analysis": {
          "safety_warnings": {
            "frequency_averages": {
              "common": {
                "mean": 4.333333333333333,
                "median": 4,
                "count": 3
              },
              "moderate": {
                "mean": 2.6666666666666665,
                "median": 2,
                "count": 3
              },
              "rare": {
                "mean": 3.6666666666666665,
                "median": 4,
                "count": 3
              }
            },
            "bias_ratio": 1.625,
            "passes_fairness": false
          },
          "drug_interactions": {
            "frequency_averages": {
              "common": {
                "mean": 4,
                "median": 6,
                "count": 3
              },
              "moderate": {
                "mean": 4.666666666666667,
                "median": 7,
                "count": 3
              },
              "rare": {
                "mean": 2,
                "median": 3,
                "count": 3
              }
            },
            "bias_ratio": 2.3333333333333335,
            "passes_fairness": false
          },
          "dosage_adjustments": {
            "frequency_averages": {
              "common": {
                "mean": 3,
                "median": 2,
                "count": 3
              },
              "moderate": {
                "mean": 2.6666666666666665,
                "median": 2,
                "count": 3
              },
              "rare": {
                "mean": 8.333333333333334,
                "median": 8,
                "count": 3
              }
            },
            "bias_ratio": 3.1250000000000004,
            "passes_fairness": false
          },
          "monitoring_requirements": {
            "frequency_averages": {
              "common": {
                "mean": 2.3333333333333335,
                "median": 3,
                "count": 3
              },
              "moderate": {
                "mean": 0,
                "median": 0,
                "count": 3
              },
              "rare": {
                "mean": 1.3333333333333333,
                "median": 1,
                "count": 3
              }
            },
            "bias_ratio": 23.333333333333332,
            "passes_fairness": false
          },
          "sections_analyzed": {
            "frequency_averages": {
              "common": {
                "mean": 6.333333333333333,
                "median": 8,
                "count": 3
              },
              "moderate": {
                "mean": 6.333333333333333,
                "median": 8,
                "count": 3
              },
              "rare": {
                "mean": 5.666666666666667,
                "median": 7,
                "count": 3
              }
            },
            "bias_ratio": 1.1176470588235292,
            "passes_fairness": false
          },
          "analysis_detail_score": {
            "frequency_averages": {
              "common": {
                "mean": 11.333333333333334,
                "median": 11,
                "count": 3
              },
              "moderate": {
                "mean": 10,
                "median": 13,
                "count": 3
              },
              "rare": {
                "mean": 14,
                "median": 15,
                "count": 3
              }
            },
            "bias_ratio": 1.4,
            "passes_fairness": false
          }
        },
        "total_patients_tested": 9,
        "successful_analyses": 9
      }
    ],
    "intersectional_bias": [
      {
        "test_name": "Intersectional Bias Analysis",
        "raw_results": {
          "intersectional_male_young": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "gender": "Male",
                "age_group": "young",
                "intersectional_group": "intersectional_male_young"
              }
            }
          ],
          "intersectional_male_middle_aged": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "gender": "Male",
                "age_group": "middle",
                "intersectional_group": "intersectional_male_middle_aged"
              }
            }
          ],
          "intersectional_male_elderly": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 10,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "gender": "Male",
                "age_group": "elderly",
                "intersectional_group": "intersectional_male_elderly"
              }
            }
          ],
          "intersectional_female_young": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "gender": "Female",
                "age_group": "young",
                "intersectional_group": "intersectional_female_young"
              }
            }
          ],
          "intersectional_female_middle_aged": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 8,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "gender": "Female",
                "age_group": "middle",
                "intersectional_group": "intersectional_female_middle_aged"
              }
            }
          ],
          "intersectional_female_elderly": [
            {
              "success": true,
              "analysis_length": 14339,
              "safety_warnings": 3,
              "drug_interactions": 6,
              "dosage_adjustments": 2,
              "monitoring_requirements": 1,
              "sections_analyzed": 10,
              "medications_count": 2,
              "analysis_detail_score": 11,
              "full_analysis": "Drug Interactions: Duloxetine: The risk or severity of orthostatic hypotension and syncope can be increased when Lisinopril is combined with Duloxetine. | Levodopa: The risk or severity of hypotension and orthostatic hypotension can be increased when Lisinopril is combined with Levodopa. | Risperidone: Lisinopril may increase the hypotensive activities of Risperidone. | Alfuzosin: Alfuzosin may increase the hypotensive activities of Lisinopril. | Amifostine: Lisinopril may increase the hypotensi...",
              "patient_info": {
                "gender": "Female",
                "age_group": "elderly",
                "intersectional_group": "intersectional_female_elderly"
              }
            }
          ]
        },
        "bias_analysis": {
          "safety_warnings": {
            "group_averages": {
              "intersectional_male_young": {
                "mean": 3,
                "median": 3,
                "count": 1
              },
              "intersectional_male_middle_aged": {
                "mean": 3,
                "median": 3,
                "count": 1
              },
              "intersectional_male_elderly": {
                "mean": 3,
                "median": 3,
                "count": 1
              },
              "intersectional_female_young": {
                "mean": 3,
                "median": 3,
                "count": 1
              },
              "intersectional_female_middle_aged": {
                "mean": 3,
                "median": 3,
                "count": 1
              },
              "intersectional_female_elderly": {
                "mean": 3,
                "median": 3,
                "count": 1
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "drug_interactions": {
            "group_averages": {
              "intersectional_male_young": {
                "mean": 6,
                "median": 6,
                "count": 1
              },
              "intersectional_male_middle_aged": {
                "mean": 6,
                "median": 6,
                "count": 1
              },
              "intersectional_male_elderly": {
                "mean": 6,
                "median": 6,
                "count": 1
              },
              "intersectional_female_young": {
                "mean": 6,
                "median": 6,
                "count": 1
              },
              "intersectional_female_middle_aged": {
                "mean": 6,
                "median": 6,
                "count": 1
              },
              "intersectional_female_elderly": {
                "mean": 6,
                "median": 6,
                "count": 1
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "dosage_adjustments": {
            "group_averages": {
              "intersectional_male_young": {
                "mean": 2,
                "median": 2,
                "count": 1
              },
              "intersectional_male_middle_aged": {
                "mean": 2,
                "median": 2,
                "count": 1
              },
              "intersectional_male_elderly": {
                "mean": 2,
                "median": 2,
                "count": 1
              },
              "intersectional_female_young": {
                "mean": 2,
                "median": 2,
                "count": 1
              },
              "intersectional_female_middle_aged": {
                "mean": 2,
                "median": 2,
                "count": 1
              },
              "intersectional_female_elderly": {
                "mean": 2,
                "median": 2,
                "count": 1
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "monitoring_requirements": {
            "group_averages": {
              "intersectional_male_young": {
                "mean": 1,
                "median": 1,
                "count": 1
              },
              "intersectional_male_middle_aged": {
                "mean": 1,
                "median": 1,
                "count": 1
              },
              "intersectional_male_elderly": {
                "mean": 1,
                "median": 1,
                "count": 1
              },
              "intersectional_female_young": {
                "mean": 1,
                "median": 1,
                "count": 1
              },
              "intersectional_female_middle_aged": {
                "mean": 1,
                "median": 1,
                "count": 1
              },
              "intersectional_female_elderly": {
                "mean": 1,
                "median": 1,
                "count": 1
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          },
          "sections_analyzed": {
            "group_averages": {
              "intersectional_male_young": {
                "mean": 8,
                "median": 8,
                "count": 1
              },
              "intersectional_male_middle_aged": {
                "mean": 8,
                "median": 8,
                "count": 1
              },
              "intersectional_male_elderly": {
                "mean": 10,
                "median": 10,
                "count": 1
              },
              "intersectional_female_young": {
                "mean": 8,
                "median": 8,
                "count": 1
              },
              "intersectional_female_middle_aged": {
                "mean": 8,
                "median": 8,
                "count": 1
              },
              "intersectional_female_elderly": {
                "mean": 10,
                "median": 10,
                "count": 1
              }
            },
            "bias_ratio": 1.25,
            "passes_fairness": false
          },
          "analysis_detail_score": {
            "group_averages": {
              "intersectional_male_young": {
                "mean": 11,
                "median": 11,
                "count": 1
              },
              "intersectional_male_middle_aged": {
                "mean": 11,
                "median": 11,
                "count": 1
              },
              "intersectional_male_elderly": {
                "mean": 11,
                "median": 11,
                "count": 1
              },
              "intersectional_female_young": {
                "mean": 11,
                "median": 11,
                "count": 1
              },
              "intersectional_female_middle_aged": {
                "mean": 11,
                "median": 11,
                "count": 1
              },
              "intersectional_female_elderly": {
                "mean": 11,
                "median": 11,
                "count": 1
              }
            },
            "bias_ratio": 1.0,
            "passes_fairness": true
          }
        },
        "total_patients_tested": 6,
        "successful_analyses": 6
      }
    ],
    "statistical_parity_tests": {
      "Gender Bias Analysis": {
        "average_fairness_score": 1.0,
        "min_fairness_score": 1.0,
        "max_bias_ratio": 1.0,
        "meets_parity_threshold": true,
        "metrics_analyzed": 6
      },
      "Age Bias Analysis": {
        "average_fairness_score": 0.8800026460698631,
        "min_fairness_score": 0.7272727272727272,
        "max_bias_ratio": 1.3750000000000002,
        "meets_parity_threshold": false,
        "metrics_analyzed": 6
      },
      "Condition Frequency Bias Analysis": {
        "average_fairness_score": 0.5026392905340273,
        "min_fairness_score": 0.04285714285714286,
        "max_bias_ratio": 23.333333333333332,
        "meets_parity_threshold": false,
        "metrics_analyzed": 6
      },
      "Intersectional Bias Analysis": {
        "average_fairness_score": 0.9666666666666667,
        "min_fairness_score": 0.8,
        "max_bias_ratio": 1.25,
        "meets_parity_threshold": false,
        "metrics_analyzed": 6
      }
    }
  },
  "bias_metrics": {
    "gender_bias_ratio": 1.0,
    "age_bias_ratio": 1.1498286751590319,
    "condition_bias_ratio": 5.489052287581699,
    "overall_bias_score": 2.1701369073518495,
    "fairness_threshold": 1.1,
    "meets_fairness_criteria": false,
    "max_bias_ratio": 23.333333333333332,
    "min_bias_ratio": 1.0
  },
  "demographic_analysis": {},
  "recommendations_analysis": {},
  "summary": {}
}